Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 5860-5872
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5860
Table 2 Results of univariate and multivariate analysis in the training set
VariableUnivariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Sex
FemaleReferenceReference
Male0.82 (0.70-0.95)0.008b1.01 (0.85-1.16)0.9277
Age at diagnosis, yr
20-55ReferenceReference
55-651.12 (0.88-1.43)0.3391.38 (1.1380-1.6278)0.0095b
65-751.17 (0.93-1.49)0.1851.470.0017b
> 752.69 (2.20-3.30)< 0.001c3.95 (3.7336-4.1610)< 0.001c
Race
BlackReferenceReference
White0.97 (0.78-1.21)0.7990.72 (0.4852-0.9513)0.0054b
Other (American Indian/Alaska Native, Asian/Pacific Islander)0.68 (0.48-0.95)0.023a0.64 (0.2921-0.9791)0.0097b
T stage
Tis1.40 (0.50-3.93)0.5241.50 (0.4674-2.5395)0.4405
T1ReferenceReference
T21.75 (1.16-2.63)0.00b1.21 (0.7887-1.6327)0.3745
T33.24 (2.30-4.57)< 0.001c1.56 (1.1640-1.9478)0.0271a
T48.30 (5.85-11.76)< 0.001c2.58 (2.1710-3.0036)< 0.001c
N stage
N0ReferenceReference
N11.85 (1.53-2.24)< 0.001c1.16 (0.9433-1.3720)0.1806
N24.49 (3.76-5.36)< 0.001c1.10 (0.7504-1.4569)0.5841
M stage
M0ReferenceReference
M15.95 (5.06-6.99)< 0.001c3.27 (3.0738-3.4599)< 0.001c
Serum CEA level
ElevatedReferenceReference
Normal0.43 (0.37-050)< 0.001c0.78 (0.6157-0.9438)0.0030b
Tumor deposit
NegativeReferenceReference
Positive3.57 (3.02-4.23)< 0.001c1.44 (1.2366-1.6385)0.0004c
Grade
I0.76 (0.55-1.05)0.0960.81 (0.4859-1.1416)0.2179
IIReferenceReference
III2.42 (2.04-2.86)< 0.001c1.14 (0.9361-1.3457)0.2071
IV2.38 (1.82-3.10)< 0.001c1.15 (0.8608-1.4452)0.3396
Tumor size
≤ 30 mmReferenceReference
30-50 mm1.98 (1.59-2.46)< 0.001c1.00 (0.7592-1.2460)0.9832
50-65 mm2.10 (1.64-2.69)< 0.001c1.11 (0.8352-1.3831)0.4585
> 65 mm2.67 (2.14-3.34)< 0.001c1.11 (0.8608-1.4452)0.4209
LODDS
≤ -0.6504ReferenceReference
> -0.65044 (3.44-4.65)< 0.001c2.20 (1.9068-2.5030)< 0.001c
LNR
≤ 0.1795Reference--
> 0.17953.97 (3.41-4.62)< 0.001c--